A pharmaceutical company claims that it has developed a drug that will decrease the likelihood of seizures in patients with epil
epsy. What should be done to insure that these claims are reliable? A. The company should share the results with the public and document the number of seizures patients have while taking the drug.
B. The results should be replicated and the research peer reviewed by scientists who will not benefit from the sale of the drug.
C. Results were published in a science journal.
D. As long as the data the pharmaceutical company collected was done so using technology, the results will be deemed reliable.
This ensures that the research is corroborated by other scientists and is peer-reviewed hence increasing the veracity of the findings. This also ensures that conflict of interest is addressed whereby the findings by the company may appear to be compromised or biased because such a finding would be in favour of their own needs (such as financial gain). Peer review in such case is even more important because it involves humans subjects and ethics are paramount in healthcare research.
